Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
Official title: Prospective Study Protocol for Multiparametric Photon Counting CT Assessment of Early Ventricular Outcomes After Coronary Artery Bypass Grafting
Run by Chinese PLA General Hospital · NCT07883499 · Data updated 2026-11-12
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Chinese PLA General Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | October 10, 2025 |
| Main results expected | October 10, 2029 |
| Study ends | October 10, 2029 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT07883499 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older scheduled for isolated CABG who can undergo the specified PCCT exams and follow-up.
✕Probably not a fit
Patients who do not show a relationship between preoperative PCCT findings and postoperative heart remodeling or who have contraindications to CT contrast may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study will use photon-counting CT scans and echocardiography before surgery, within 7 days after surgery, and around 3 months postoperatively to see if preoperative heart tissue information can predict left ventricular end-systolic volume index after surgery. The study focuses on adults undergoing isolated CABG and will exclude those needing additional major cardiac procedures or with contraindications to contrast-enhanced CT. Primary task is to relate preoperative imaging markers to postoperative cardiac remodeling, adjusting for body size. Blood tests and imaging will be used to characterize patients, with follow-up to ensure data completeness. No interventional treatment is described; the goal is observational insight for future risk stratification.
Why it matters
Potential benefit: If successful, the approach could help identify patients at higher risk of suboptimal heart recovery after CABG using noninvasive imaging.
How similar studies have gone: Previous imaging-based studies have shown potential in predicting cardiac outcomes, but this exact photon-counting CT approach in CABG patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years and scheduled for isolated CABG. 2. Able to undergo the protocol-specified PCCT examinations after assessment by the clinical and imaging teams. 3. Able to understand the study and provide written informed consent, and willing to attend the 3-month postoperative follow-up. Exclusion Criteria: 1. Planned concomitant major cardiac surgery, such as valve or aortic surgery, that places the patient outside the target population of isolated CABG. 2. A clinically assessed contraindication to contrast-enhanced CT, including a severe iodinated contrast allergy that cannot be adequately managed, pregnancy, or another examination contraindication. 3. Clinical condition precluding research examinations, or a research workflow that could delay necessary treatment. 4. Unable to complete the informed consent process or explicitly unwilling to attend the required follow-up.
Where it's running
-
Department of Radiology, the First Medical Center of Chinese PLA General Hospital/ Chinese PLA Medical School, Beijing, China
Beijing, China Recruiting
Study contacts
- Study coordinator: Xiaomeng Fan
- Email: fanxiaomeng@301hospital.com.cn
- Phone: 18515817177
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.